CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-18 | Berg Edward B SVP, General Counsel | Shares withheld for taxes | −8,050 | $0.57 | $5K | 288,123 |
| 2025-03-18 | Cummings James F. Chief Medical Officer | Shares withheld for taxes | −6,772 | $0.57 | $4K | 343,049 |
| 2025-03-18 | Lo Steven President, Chief Exec Officer | Shares withheld for taxes | −22,362 | $0.57 | $13K | 227,638 |
| 2025-03-18 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −8,050 | $0.57 | $5K | 338,403 |
| 2025-03-18 | Lee Phillip E Chief Financial Officer | Shares withheld for taxes | −8,050 | $0.57 | $5K | 225,619 |
| 2025-02-02 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −9,242 | $0.68 | $6K | 346,453 |
| 2025-02-02 | Cummings James F. Chief Medical Officer | Shares withheld for taxes | −7,964 | $0.68 | $5K | 318,837 |
| 2025-02-02 | Berg Edward B SVP, General Counsel | Shares withheld for taxes | −9,242 | $0.68 | $6K | 261,464 |
| 2025-01-28 | Finney Kevin Director | Grant or award | +32,000 | 32,000 | ||
| 2025-01-28 | Finney Kevin Director | Grant or award · Stock Option (right to buy) | +190,800 | 190,800 | ||
| 2024-12-15 | Lee Phillip E Chief Financial Officer | Shares withheld for taxes | −6,132 | $0.59 | $4K | 233,669 |
| 2024-06-18 | Watson W. Mark Director | Purchase | +20,000 | $0.68 | $14K | 78,125 |
| 2024-06-12 | Lee Phillip E Chief Financial Officer | Shares withheld for taxes | −2,007 | $0.76 | $2K | 239,801 |
| 2024-06-11 | Wheadon David E. Director | Grant or award | +16,000 | 30,750 | ||
| 2024-06-11 | Wheadon David E. Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2024-06-11 | Finney Michael J. Director | Grant or award | +16,000 | 686,840 | ||
| 2024-06-11 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2024-06-11 | HERON ELAINE J Director | Grant or award | +16,000 | 40,566 | ||
| 2024-06-11 | HERON ELAINE J Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2024-06-11 | Watson W. Mark Director | Grant or award | +16,000 | 58,125 |
Page 5 of 10 · 198 trades